S Traoré

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

The incidence of acute oxaliplatin-induced neuropathy and its impact on treatment in the first cycle: a systematic review

Cancer treatment and survivorship statistics, 2022

Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients

Review of therapeutic drug monitoring of anticancer drugs part 1 – Cytotoxics

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update

Polymorphic markers associated with severe oxaliplatin‐induced, chronic peripheral neuropathy in colon cancer patients

Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: A prospective quantified sensory assessment study

Central sensitization: Implications for the diagnosis and treatment of pain

Colorectal cancer

The Challenges of Colorectal Cancer Survivorship

Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics

Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis

Schistosomiasis

Gut microbiota modulation of chemotherapy efficacy and toxicity

Cerebrospinal fluid metabolomics identifies 19 brain-related phenotype associations

Targeted therapy in metastatic colorectal cancer – An example of personalised medicine in action

Cellular and Molecular Mechanisms of Pain

Taenia solium taeniosis/cysticercosis and the co-distribution with schistosomiasis in Africa

Practical Recommendations for Pharmacogenomics-based Prescription: 2010 ESF–UB Conference on Pharmacogenetics and Pharmacogenomics

Fluoropyrimidine-associated cardiotoxicity: revisited

Neuropathic Pain: From Mechanisms to Treatment

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

Cancer treatment and survivorship statistics, 2019

MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights

[Human parasitoses in Burkina Faso. Histopathologic approach].

5-Fluorouracil-related severe toxicity: A comparison of different methods for the pretherapeutic detection of dihydropyrimidine dehydrogenase deficiency

Clinical relevance of different dihydropyrimidine dehydrogenase gene single nucleotide polymorphisms on 5-fluorouracil tolerance

Predictive Factors of Oxaliplatin Neurotoxicity: The Involvement of the Oxalate Outcome Pathway

PANERB study: Panitumumab after cetuximab-based regimen failure.